---
figid: PMC6586801__12276_2019_235_Fig2_HTML
figtitle: Hypoxia signaling in human diseases and therapeutic targets
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Escherichia coli
- Oryctolagus cuniculus
- Mirabilis mosaic virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Oryctolagus cuniculus
- Drosophila melanogaster
pmcid: PMC6586801
filename: 12276_2019_235_Fig2_HTML.jpg
figlink: /pmc/articles/PMC6586801/figure/Fig2/
number: F2
caption: During the hypoxic insult, cells release adenosine triphosphate/adenosine
  diphosphate (ATP/ADP) that accumulate in the extracellular space. Hypoxia triggers
  the SP1-dependent induction of CD39 and HIF-dependent induction of CD73, which converts
  ATP to ADP, AMP, and eventually adenosine. HIF also upregulates adenosine receptor
  levels and together with the increased extracellular adenosine, the downstream purinergic
  signaling pathway is activated. Extracellular adenosine could re-enter into the
  cell by equilibrative nucleoside transporters (ENTs) or could be deaminated by CD26-conjugated
  adenosine deaminases (ADAs), all of which function to terminate adenosine signaling.
  Stimulation of adenosine receptors either result in the inhibition of adenylyl cyclase
  (AC) by ADORA1/3 or activation by ADORA2A/2B
papertitle: Hypoxia signaling in human diseases and therapeutic targets.
reftext: Jae W. Lee, et al. Exp Mol Med. 2019 Jun;51(6):68.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9685029
figid_alias: PMC6586801__F2
figtype: Figure
redirect_from: /figures/PMC6586801__F2
ndex: 97226581-deb2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6586801__12276_2019_235_Fig2_HTML.html
  '@type': Dataset
  description: During the hypoxic insult, cells release adenosine triphosphate/adenosine
    diphosphate (ATP/ADP) that accumulate in the extracellular space. Hypoxia triggers
    the SP1-dependent induction of CD39 and HIF-dependent induction of CD73, which
    converts ATP to ADP, AMP, and eventually adenosine. HIF also upregulates adenosine
    receptor levels and together with the increased extracellular adenosine, the downstream
    purinergic signaling pathway is activated. Extracellular adenosine could re-enter
    into the cell by equilibrative nucleoside transporters (ENTs) or could be deaminated
    by CD26-conjugated adenosine deaminases (ADAs), all of which function to terminate
    adenosine signaling. Stimulation of adenosine receptors either result in the inhibition
    of adenylyl cyclase (AC) by ADORA1/3 or activation by ADORA2A/2B
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wdtc1
  - Mdga2
  - Entpd1
  - Nt5e
  - Ada
  - ac
  - Dpp4
  - Adora2b
  - Adora1
  - Adora2a
  - WDTC1
  - APRT
  - MFAP1
  - ENTPD1
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - NT5E
  - ADA
  - ADAD1
  - ADAD2
  - ADAR
  - ADARB1
  - ADARB2
  - ADAT1
  - ADAT2
  - ADAT3
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - DPP4
  - ADORA2B
  - ADORA1
  - ADORA2A
  - ATP8A2
  - Svs4
  - Tmprss5
  - adp
  - Amph
  - AP-2alpha
  - ATPsynbeta
  - Atpalpha
  - Adenosine
  - ADP
  - AMP
  - Inosine
---
